Results 141 to 150 of about 1,106,155 (263)

Autoimmune lymphoproliferative syndrome: a multifactorial disorder

Haematologica, 2010
Frédéric Rieux-Laucat, Aude Magerus-Chatinet   +1 more
doaj   +1 more source

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study

Respirology, Volume 31, Issue 9, Page 903-911, September 2026.
We assessed the diagnostic yield of EBUS‐guided transbronchial mediastinal cryobiopsy (EBUS‐TBMC) compared with EBUS‐transbronchial needle aspiration (EBUS‐TBNA) in patients with suspected mediastinal lymphoproliferative disorders (LPDs). EBUS‐TBMC was superior to EBUS‐TBNA and achieved a high diagnostic yield in patients with suspected mediastinal ...
Yaniv Dotan, Ayal Romem, Elad Guber, Michael Kassirer, Daphne Felus, Nimrod Urtreger, Ophir Freund, Hanna A. Dawood, Boaz Tiran, Doron Cohn‐Schwartz, Sarah Borsekofsky, Amir Bar‐Shai, Evgeni Gershman   +12 more
wiley   +1 more source

Early Posttransplant Lymphoproliferative Disorder and Cryptosporidiosis After Liver Transplantation. [PDF]

Case Rep Med
Hakamifard A, Abolghasemi S, Hatami B, Mangeli F, Momenzadeh M.   +4 more
europepmc   +1 more source

Cirrhosis Impairs Reconstitution of the Circulating T‐Lymphocyte Compartment After Direct‐Acting Antiviral Therapy for Hepatitis C Virus Infection

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Background Direct‐acting antivirals (DAAs) achieve sustained virological response (SVR) in over 95% of patients with chronic hepatitis C virus (HCV) infection. Although viral eradication allows partial immune restoration, it remains unclear whether established cirrhosis limits recovery of the circulating T lymphocyte compartment after SVR ...
Lorena Paule, Elisa Castillo, Leticia Muñoz, Javier Martínez, Carlos Fernández, Alejandro Miranda, Margaret Lario, Jorge Monserrat, Miguel Ángel Ortega, José Luis Calleja, Melchor Álvarez‐Mon, Agustín Albillos   +11 more
wiley   +1 more source

Post-transplant lymphoproliferative disorder after solid organ transplantation: a comprehensive review. [PDF]

Front Transplant
Vargas-Nieto LP, Santoyo-Sarmiento ND, Ballesteros-García M, Calderón-Vásquez AT, Pinto-Rodriguez ÁD, Robayo-Romero MG, Cormane-Alfaro V, Daza-Buitrago J.   +7 more
europepmc   +1 more source

Phenotype‐specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20‐year cohort study

British Journal of Haematology, Volume 209, Issue 3, Page 1158-1165, September 2026.
Summary Childhood autoimmune neutropenia (AIN) encompasses heterogeneous entities; phenotype‐specific immunological profiles and their relationship to infection outcomes remain incompletely defined. To characterise clinical, immunological and long‐term outcomes across distinct phenotypes of childhood AIN.
Ioanna Saougou, Chrysoula Kosmeri, Nikolaos Chaliasos, Irene Mavroudi, Charalampos Pontikoglou, Alexandros Makis   +5 more
wiley   +1 more source

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study. [PDF]

Ann Transplant
Liu Y, Cai RZ, Qu W, Wei L, Zeng ZG, Zhu ZJ, Sun LY.   +6 more
europepmc   +1 more source

Occurrence of post-transplant lymphoproliferative disorders among over thousandadult recipients: any role for hepatitis C infection?

, 2006
BACKGROUND: Post-transplant lymphoproliferative disorders represent an increasingly important complication of organ transplantation. Although the majority of the post-transplant lymphoproliferative disorder are etiologically related to Epstein-Barr virus
CANOVA D, ZANUS G, LUCIANA AVERSA SM, RIGOTTI, PAOLO, CALABRESE, FIORELLA, LIVI U, BURRA, PATRIZIA, FARINATI, FABIO, BUDA A, CAFORIO A, MENIN, C   +10 more
core  

Exosomal miRNA expression in transplant recipients with EBV-associated post-transplant lymphoproliferative disorder. [PDF]

Front Immunol
Pociupany M, Snoeck R, Dierickx D, Andrei G.   +3 more
europepmc   +1 more source

A real‐world study on different initiation times and treatment durations of letermovir for cytomegalovirus prophylaxis after allogeneic haematopoietic stem cell transplantation

British Journal of Haematology, Volume 209, Issue 3, Page 1198-1207, September 2026.
Early letermovir initiation (day 0) after allogeneic haematopoietic stem cell transplantation (allo‐HSCT) reduced early cytomegalovirus (CMV) infection and delayed first CMV DNAemia compared with later starts. Extending prophylaxis to 200 days virtually eliminated late CMV reactivation and improved 1‐year overall survival, with no grade ≥3 drug‐related
Shiyu Chen, Zhihang Su, Xiaohan Zhang, Xiaoqing Li, Xin Du   +4 more
wiley   +1 more source